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Trans-Atlantic Debate: Whether Carotid Endarterectomy is Safer than
Stenting in the Hyperacute Period After Onset of Symptoms
T.L. Forbes
Division of Vascular Surgery, University of Toronto, 200 Elizabeth St, Eaton North 6-222, Toronto, ON M5G2C4, Canada
The carotid artery has been a regular battleground for de-
bates regarding many issues, including appropriate man-
agement of symptomatic and asymptomatic lesions, the
conduct, timing and safety of such interventions, and now
whether endarterectomy or stenting is safer in the
hyperacute period. Our discussants agree that, as a pro-
phylactic procedure, a carotid intervention should occur
early after index symptoms to prevent as many strokes as
possible. However, which intervention is best?
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WHY ARE WE HAVING THIS DEBATE?
The updated 2014 American Heart Association (AHA)
guidelines advise that carotid endarterectomy (CEA) be
considered in patients presenting with a transient ischaemic
attack (TIA) or ischaemic stroke in the preceding 6 months,
and who have an ipsilateral 50e99% carotid stenosis, pro-
vided perioperative morbidity/mortality is < 6% (class I,
level of evidence A for 70e99% stenoses; class I, level of
evidence B for 50e69% stenoses).1 However, this “6-
month” threshold for intervening is a historical “quirk”
and has been retained within guidelines since the early
1990s. Rather than being based on evidence, it simply re-
ﬂects surgeon/neurologist equipoise relating to the time
period that was considered appropriate for randomizing
symptomatic patients within the international trials over
three decades ago.
Over the last 10 years, increasingly compelling evidence
suggests that the risk of stroke after suffering a TIA is very
much front loaded (rather than being evenly distributed
across the 6-month time period), with the highest-risk
period being the ﬁrst 14 days after onset of symptoms.
Thereafter, the beneﬁt conferred by CEA diminishes, and if
CEA is delayed by >12 weeks, only eight strokes will be
prevented at 5 years per 1,000 CEAs performed2; that is
992 of 1,000 patients receiving CEA will undergo an ulti-
mately unnecessary intervention From the historical
perspective, it is important to be aware that had the Eu-
ropean Carotid Surgery Trial (ECST) been dominated by
centres taking > 50 days to perform CEA (from symptom
onset), the ECST would not have shown signiﬁcant beneﬁt
favouring surgery.3 In a pooled series of > 500 patients
whose stroke was preceded by a TIA, 43% of strokes
happened within the ﬁrst 7 days of the index TIA,4 with a
third happening on the same day as the TIA. A meta-
analysis of data from the ECST, the North American
Symptomatic Carotid Endarterectomy Trial (NASCET), and
the Veterans Affairs (VA) trial has shown that CEA
conferred maximum beneﬁt (in terms of strokes prevented)
when undertaken within 14 days.2 This was particularly
evident in women, and the meta-analysis suggested that
few women beneﬁtted from CEA (even those with 70e99%
stenoses) if > 4 weeks had elapsed before undergoing
CEA.5 These data were responsible for guidelines by the
National Institute for Health and Care Excellence (2008) and
the European Society of Vascular Surgery (2009) advising
that CEA should be performed within 14 days of the index
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